Repurposing the antipsychotic drug penfluridol for cancer treatment (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8833
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2024 AND VI 52 AND IP 6
Results: 16
1
2
HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA methylation.
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8832
- By:
- Publication type:
- Article
3
Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma.
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8831
- By:
- Publication type:
- Article
4
[Retracted] lncRNA TTN‑AS1 upregulates RUNX1 to enhance glioma progression via sponging miR‑27b‑3p.
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8830
- By:
- Publication type:
- Article
5
GOLPH3 inhibition overcomes cisplatin resistance by restoring the glutathione/reactive oxygen species balance in the A549 non‑small cell lung cancer cell line.
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8829
- By:
- Publication type:
- Article
6
Role of SIK1 in tumors: Emerging players and therapeutic potentials (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8828
- By:
- Publication type:
- Article
7
[Corrigendum] Nucleosome‑binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2‑OS osteosarcoma cell lines.
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8827
- By:
- Publication type:
- Article
8
Flavonoids as modulators of metabolic reprogramming in renal cell carcinoma (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8826
- By:
- Publication type:
- Article
9
[Retracted] SET and MYND domain‑containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity.
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8825
- By:
- Publication type:
- Article
10
Effect of colony‑stimulating factor in the mechanism of bone metastasis development (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8824
- By:
- Publication type:
- Article
11
Biomarkers for evaluating the clinical response to immune checkpoint inhibitors in renal cell carcinoma (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8823
- By:
- Publication type:
- Article
12
[Corrigendum] BMP‑6 inhibits the metastasis of MDA‑MB‑231 breast cancer cells by regulating MMP‑1 expression.
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8822
- By:
- Publication type:
- Article
13
Oncogenic mechanisms of COL10A1 in cancer and clinical challenges (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8821
- By:
- Publication type:
- Article
14
[Retracted] LncRNA TTN‑AS1 promotes endometrial cancer by sponging miR‑376a‑3p.
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8820
- By:
- Publication type:
- Article
15
[Retracted] hsa‑miR‑212 modulates the radiosensitivity of glioma cells by targeting BRCA1.
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8818
- By:
- Publication type:
- Article
16
Progress of research on γδ T cells in colorectal cancer (Review).
- Published in:
- Oncology Reports, 2024, v. 52, n. 6, p. N.PAG, doi. 10.3892/or.2024.8819
- By:
- Publication type:
- Article